Table 10.
KM Cumulative Risk Rates through 10 Years for Baker Class III or IV Capsular Contracture in Primary Augmentation
| Core Study | Primary Augmentation (%) | Revision Augmentation (%) | Combined (%)a |
|---|---|---|---|
| Ideal Implant | 6.6 | 11.5 | |
| Allergan Silicone Gel2 | 18.9 | 28.7 | |
| Mentor Silicone Gel3 | 12.1 | 24.4 | |
| Sientra Silicone Gel4 | 12.9 | 13.7 | |
| Allergan Saline14 | 20.8 | ||
| Mentor Saline15 | 17.5 |
Primary and revision augmentation not reported separately.